< 1 minute read
Sep. 18, 2021

BAY-6672

oral prostaglandin F receptor GCPR antagonist to treat IPF, in vivo efficacy in fibrosis model from ~3M cmpd cell-based HTS and opt. J. Med. Chem., Oct. 22, 2020 issue Bayer AG, Wuppertal, DE

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in